Peter Tai Wah Cheng

This inventor holds 24 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 20 EPO patents, primarily in LPA Antagonists. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited, Other. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Tai Wah Cheng. Retrieved from https://idiyas.com/inventor/peter-tai-wah-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 20 (Patent Applications = 17)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 89(Granted Patents)

Company Filing History:

23 out of 3,742

Bristol-Myers Squibb Compnay

patents

1 out of 7

Syngene International Limited

patents

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

LPA Antagonists

Cyclobutyl Acids

Triazole Carboxylic Acids

Isoxazole Acids

Carbamoyl Acids

Cyclohexyl Acids

Pyrazole Compounds

N-Linked Compounds

O-Linked Compounds

Glucokinase Activators

Chemical Compounds

Pharmaceuticals

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466804 - Cyclobutyl carboxylic acids as LPA antagonists (2025-11-11),

2. 12435057 - Triazole carboxylic acids as LPA antagonists (2025-10-07),

3. 12428430 - Oxabicyclo acids as LPA antagonists (2025-09-30),

4. 12384768 - Isoxazole carboxylic acids as LPA antagonists (2025-08-12),

5. 12209072 - Cyclopentyl acids as LPA antagonists (2025-01-28),

6. 12195444 - Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists (2025-01-14),

7. 11697646 - Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists (2023-07-11),

8. RE49352 - Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists (2023-01-02),

9. 11447475 - Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists (2022-09-20),

10. 11384067 - Pyrazole n-linked carbamoyl cyclohexyl acids as LPA antagonists (2022-07-12),

11. 11352345 - Cyclohexyl acid pyrazole azoles as LPA antagonists (2022-06-07),

12. 11319315 - Cyclohexyl acid triazole azoles as LPA antagonists (2022-05-03),

13. 11319309 - Cyclohexyl acid isoxazole azines as LPA antagonists (2022-05-03),

14. 11312706 - Cyclohexyl acid pyrazole azines as LPA antagonists (2022-04-26),

15. 11267800 - Cyclohexyl acid triazole azines as LPA antagonists (2022-03-08),

Title: The Innovative Journey of Peter Tai Wah Cheng

Introduction: Peter Tai Wah Cheng, a pioneering inventor based in Princeton, NJ, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Peter Tai Wah Cheng holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Peter Tai Wah Cheng has worked tirelessly to push the boundaries of technological advancements. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations: Throughout his career, Peter Tai Wah Cheng has collaborated with leading research institutions, universities, and tech companies to further develop and implement his inventions. His collaborative efforts have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Peter Tai Wah Cheng's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His dedication to creating impactful solutions to complex problems continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.